Wearable Dry-Electrode ECG Shows Excellent Agreement with Laboratory Reference System

We are excited to share new proof-of-concept results evaluating the X-trodes System M wearable dry-electrode ECG platform against a conventional wired laboratory reference system: Link

.

Wearable ECG technologies have the potential to transform cardiac monitoring by enabling recordings over longer periods and under more natural conditions. However, for such systems to provide meaningful physiological and clinical information, it is essential to establish that cardiac events can be measured with high temporal fidelity compared with established reference systems.

In this study, 20 participants—10 healthy volunteers and 10 cardiology patients—underwent simultaneous ECG recordings using the FDA-cleared X-trodes System M and a wired Biopac reference system. The comparison focused on the accuracy of cardiac intervals derived independently from the two recordings.

The results demonstrated excellent agreement in RR intervals, with intraclass correlation coefficients (ICC) exceeding 0.99 in both healthy participants and cardiac patients. Mean absolute errors were approximately 1 ms in the healthy cohort and 1.3 ms in the cardiac cohort. Strong agreement was also observed for P-to-R peak intervals, providing encouraging evidence that the wearable dry-electrode platform can preserve fine temporal features of the ECG signal.

Why do accurate cardiac intervals matter?

The ECG contains considerably more information than heart rate alone. Precise beat-to-beat timing provides quantitative markers of cardiac rhythm, conduction, and autonomic regulation. RR intervals form the basis for heart-rate variability (HRV) analysis and for identifying changes in cardiac rhythm, while intervals involving the P wave provide information related to atrial activation and atrioventricular conduction.

For short clinical ECG recordings, millisecond-level timing can readily be obtained using conventional wired systems. The opportunity offered by wearable technology is to preserve this measurement fidelity while extending observation from minutes in the clinic to hours or potentially days during everyday life. Such continuous measurements could help characterize intermittent abnormalities that may not appear during a short clinical recording, quantify changes associated with activity and sleep, and reveal longitudinal physiological patterns that are difficult to capture in the laboratory.

This is why the combination of measurement fidelity, wearability, and recording duration matters. A comfortable sensor is useful only if the physiological information it provides remains reliable; conversely, a highly accurate system has limited value for continuous monitoring if it cannot be comfortably worn for extended periods.

The X-trodes technology combines soft, conformal dry electrodes with wearable electronics, potentially allowing high-quality electrophysiological monitoring to extend beyond conventional short recordings. Eliminating the need for traditional gel-based electrodes may improve comfort and facilitate longer-term measurements, while the flexible form factor is designed to support measurements during more natural daily activity.

The present study represents an important proof of concept rather than definitive clinical validation. Recordings were performed under controlled, short-duration daytime conditions, and the number of participants was relatively small. The next important step is therefore to determine whether this interval-level fidelity can be maintained during long-duration ambulatory recordings, across larger and more diverse patient populations and under the motion and environmental conditions encountered in everyday life.

The work reflects a broader goal of our research: bringing high-fidelity electrophysiology out of the laboratory and into everyday life. Combining clinical-quality physiological information with comfortable, unobtrusive wearable interfaces could open new possibilities for continuous cardiac monitoring, longitudinal assessment, and personalized digital health.